Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 58 of 97, showing 5 Applications out of 482 total, starting on record 286, ending on 290

# Protocol No Study Title Investigator(s) & Site(s)

286.

ECCT/15/06/03   DolutegrAvir With NRTIs as second-line treatment (DAWNING)
    A Phase 3b, randomised, open-label study of the antiviral activity and safety of dolutegravir compared to lopinavir/ritonavir both administered with dual nucleoside reverse transcriptase inhibitor therapy in HIV-1 infected adult subjects with treatment failure on first line therapy   
Principal Investigator(s)
1. Dr. Evans Inyangala Amukoye
2. Dr. Maricianah Atieno Onono
Site(s) in Kenya
1. Center for Respiratory Diseases Research, CRDR, KEMRI, Nairobi (Nairobi City county)
2. KEMRI-Research Care and Training Program (RCTP), Family AIDS Care and Education Services (FACES), Lumumba health centre (Kisumu county)
 
View

287.

ECCT/21/07/05   CARES
    A Phase 3b, Randomized, Multicenter, Open-Label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-Acting Cabotegravir Plus Long-Acting Rilpivirine from Current Antiretroviral Regimen in HIV-1 Infected, Virologically Suppressed Adults in Sub-Saharan Africa       
Principal Investigator(s)
1. Dr Reena Shah
Site(s) in Kenya
1. Aga Khan University Hospital Nairobi (Nairobi City county)
2. KEMRI Walter Reed Project (Kericho county)
3. Moi University Clinical Research Centre (Uasin Gishu county)
 
View

288.

ECCT/24/01/03   Doxy Short Course
    A Phase 4 Study of a 3-Day Vs. 7-Day Regimen of Doxycycline for the Treatment of Chlamydial Infection.   
Principal Investigator(s)
1. Jackson Nyangaresi Nyandoro
2. Nelly Rwamba Mugo
Site(s) in Kenya
1. Pwani Research Centre (Mombasa county)
2. KEMRI CCR-PHRD (Nairobi City county)
 
View

289.

ECCT/21/11/06   RESOLVE
    A Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Voxelotor for the Treatment of Leg Ulcers in Patients with Sickle Cell Disease    
Principal Investigator(s)
1. Videlis Nduba
Site(s) in Kenya
1. KEMRI/CRDR Siaya Clinical Research Annex (Siaya county)
2. KEMRI CRDR Clinical Research Clinic Nairobi (Nairobi City county)
 
View

290.

ECCT/21/10/02   RESOLVE
    A Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Voxelotor for the Treatment of Leg Ulcers in Patients with Sickle Cell Disease   
Principal Investigator(s)
1. Janet Oyieko
Site(s) in Kenya
1. KEMRI CCR- Butere County Hospital (Kisumu county)
2. Strathmore University (Nairobi City county)
3. KEMRI Kondele Children’s Hospital (Kisumu county)
4. KEMRI/CRDR Siaya Clinical Research Annex (Siaya county)
5. KEMRI CRDR Clinical Research Clinic Nairobi (Nairobi City county)
6. Gertrude’s Children’s Hospital (Nairobi City county)
 
View